Queen’s University Belfast PhD MDBS Guide 2026

Why Choose a Queen’s University Belfast PhD in Biomedical Sciences

Choosing where to pursue a doctoral degree is one of the most consequential decisions in an academic career. A Queen’s University Belfast PhD in the School of Medicine, Dentistry and Biomedical Sciences (MDBS) offers a compelling combination of world-class research infrastructure, generous funding packages, and a vibrant international community that few institutions can match. As a member of the prestigious Russell Group of research-intensive universities, Queen’s has consistently demonstrated its commitment to pioneering discoveries that transform healthcare outcomes globally.

Founded in 1845, Queen’s University Belfast carries over 175 years of academic tradition while maintaining a forward-looking approach to doctoral training. The university’s position in the Times Higher Education World University Rankings places it among the top 150 institutions worldwide for research quality, a testament to the calibre of supervision and facilities available to PhD students. For prospective doctoral candidates in biomedical sciences, this means joining a research ecosystem that has attracted over £30 million in research income across key disciplines including genomics, rare diseases, and multiomic analysis.

The 4-year PhD programme structure within MDBS is specifically designed to provide a more comprehensive research experience than standard 3-year programmes. This additional year allows students to develop both depth in their specialist area and breadth across transferable skills including leadership, innovation, and enterprise — qualities that the Thomas J. Moran Graduate School cultivates through its dedicated development programmes. If you are considering doctoral study in the UK, exploring other Russell Group PhD programmes can help you compare options and find the best fit for your research ambitions.

About the School of Medicine, Dentistry and Biomedical Sciences

The School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast sits within the Faculty of Medicine, Health and Life Sciences, one of the university’s largest and most research-active faculties. MDBS encompasses a remarkably broad spectrum of biomedical research, from fundamental molecular biology and genomics through to clinical trials, public health interventions, and cutting-edge pharmaceutical development. This breadth means that PhD students can pursue highly specialised research questions while benefiting from the interdisciplinary collaboration that characterises modern biomedical science.

The school’s research portfolio spans ten distinct thematic areas, each led by internationally recognised academics who serve as PhD supervisors. These areas include medical education, public health, cancer research, respiratory medicine, immunology and microbes, oral health, eye health, drug delivery and biomaterials, nanomedicine and biotherapeutics, and cardiovascular medicine. What distinguishes MDBS from comparable departments at other UK universities is the genuine integration between clinical practice and laboratory research — many projects involve direct collaboration with the Belfast Health and Social Care Trust, giving PhD students access to real patient cohorts and clinical data that enrich their research.

The school also maintains strategic partnerships with major national research initiatives, including Genomics England (GeL), Our Future Health, and the Northern Ireland Cohort of Longitudinal Ageing (NICOLA). These collaborations provide PhD students with access to some of the largest and most comprehensive biomedical datasets available anywhere, enabling research at a scale that would be impossible within a single institution. For students interested in the intersection of artificial intelligence and biomedicine, several MDBS projects explicitly incorporate machine learning and computational approaches alongside traditional wet-lab methodologies.

Queen’s University Belfast PhD Research Areas and Projects

The 2024 projects booklet for the Queen’s University Belfast PhD programme in MDBS presents over 60 individual research projects across ten major themes. Each project has been carefully designed by leading researchers to address critical questions in contemporary biomedical science, and every project comes with a clearly defined supervisory team, methodology, and expected outcomes. Understanding the breadth of these research areas is essential for prospective applicants who want to match their interests with the right supervisory team.

In the Public Health cluster, projects tackle some of the most pressing challenges facing modern healthcare systems. Dr Guillermo Lopez Campos leads a fascinating project on Digitalovigilance — the discovery and management of adverse reactions in digital health interventions — which sits at the intersection of public health, data science, and digital therapeutics. Dr Gareth McKay’s project on nutrigenomic investigation of cognitive outcomes within the NICOLA cohort leverages Northern Ireland’s longitudinal ageing study to explore how nutrition and genetics interact to influence brain health in older adults.

Professor Amy Jayne McKnight, one of the school’s most prolific researchers with a research portfolio exceeding £30 million, supervises three interconnected projects exploring multiomic signatures in healthy ageing, innovative approaches to detecting rare kidney conditions, and improving diagnosis for people living with rare diseases. These projects exemplify the school’s strength in combining large-scale genomic data with clinical insights to generate discoveries with genuine translational potential. Students working in Professor McKnight’s group gain expertise in both computational analysis and experimental techniques, making them exceptionally well-prepared for careers at the academic-industry interface.

The Medical Education theme, led by Dr Andrew Spence and Professor Gerry Gormley, takes a distinctive approach by applying rigorous qualitative research methods to understand how simulation-based education shapes the professional development of medical students. This project is ideal for candidates interested in health professions education research, a rapidly growing field with excellent career prospects in medical schools worldwide.

Cancer Research and Immunology PhD Programmes at Queen’s Belfast

Cancer research represents one of the strongest pillars of the Queen’s University Belfast PhD programme within MDBS. The cancer research cluster features six dedicated projects addressing fundamental questions about tumour biology, treatment resistance, and novel therapeutic strategies. Projects include investigating the epigenetic basis of chemotherapy resistance in colorectal cancer and identifying cancer vaccine targets in azacitidine-treated acute myeloid leukaemia (AML). These studies are supported by access to the Northern Ireland Cancer Registry, one of the most comprehensive population-based cancer databases in the UK, as well as state-of-the-art molecular biology and genomics facilities.

The Immunology and Microbes cluster is the largest in the MDBS programme, featuring sixteen individual projects that span macrophage immune responses, bacterial pathogenesis, neuro-immune interactions, and COPD signalling pathways. This exceptional breadth reflects Queen’s University Belfast’s position as a leading centre for immunological research, with particular strengths in understanding how the immune system interacts with infectious agents and how these interactions can be therapeutically manipulated. PhD students in this cluster benefit from access to cutting-edge flow cytometry, confocal microscopy, and single-cell sequencing platforms that enable research at the highest international standard.

What makes the cancer and immunology PhD programmes at Queen’s Belfast particularly attractive is the genuine interdisciplinary collaboration between research groups. Students investigating cancer biology regularly interact with immunology researchers, creating opportunities for cross-pollination of ideas and techniques that can lead to breakthrough discoveries. The Queen’s University research environment actively encourages this kind of collaborative working, with shared seminars, journal clubs, and annual research symposia that bring together PhD students from across MDBS themes.

For prospective students comparing cancer research PhD opportunities across the UK, the combination of project diversity, world-class supervision, and access to clinical datasets makes Queen’s Belfast a standout choice. The university’s participation in national cancer research networks further enhances the visibility and impact of PhD research conducted within this cluster, opening doors to post-doctoral opportunities at leading cancer centres worldwide.

Drug Delivery, Nanomedicine and Pharmaceutical PhD Research

The pharmaceutical sciences represent another area of exceptional strength within the Queen’s University Belfast PhD programme, with two closely related research clusters — Drug Delivery and Biomaterials (14 projects) and Nanomedicine and Biotherapeutics (10 projects) — offering an extraordinary range of opportunities for students interested in translational pharmaceutical research. These clusters reflect the unique advantage of Queen’s Belfast in housing both the School of Pharmacy and MDBS within the same faculty, enabling genuine cross-disciplinary collaboration that accelerates the journey from laboratory discovery to clinical application.

The Drug Delivery and Biomaterials cluster includes pioneering projects in 3D-printed implants for controlled drug release, intra-oral delivery devices, ocular drug delivery systems, mucoadhesive lubricants, intravaginal rings for reproductive health, and novel statin formulations for bacterial vaginosis. Each project combines materials science, pharmacology, and clinical need to develop innovative solutions that could transform how medicines are administered and absorbed. PhD students in this cluster gain hands-on experience with advanced manufacturing techniques including 3D printing, electrospinning, and hot-melt extrusion, as well as comprehensive formulation science and in vitro/in vivo evaluation methods.

The Nanomedicine and Biotherapeutics cluster pushes the boundaries of what is possible in targeted drug delivery. Projects include designing peptide nanoparticles for brain delivery, developing infection-responsive coatings for medical devices, engineering novel urinary catheter materials that resist biofilm formation, creating peptide hydrogels for tissue regeneration, and harnessing bacteriophages to control the oral microbiota. These projects are at the forefront of global research in nanoscale therapeutics and represent some of the most exciting opportunities available to PhD students anywhere in the UK. For students weighing pharmaceutical PhD options, understanding how different institutions approach UK pharmacy PhD research can provide valuable perspective.

The pharmaceutical research clusters benefit from exceptional laboratory facilities and strong industry connections. Queen’s University Belfast has established collaborative research partnerships with pharmaceutical companies, NHS trusts, and medical device manufacturers that provide PhD students with exposure to the commercial aspects of drug development alongside their academic research. This dual focus on scientific rigour and commercial awareness is increasingly valued by employers in the pharmaceutical and biotech sectors.

Queen’s University Belfast PhD Funding and Scholarships

One of the most important considerations for prospective PhD applicants is funding, and the Queen’s University Belfast PhD programme in MDBS offers some of the most competitive funding packages available in the UK. Many projects in the 4-year programme are fully funded, covering both tuition fees and providing a tax-free stipend for living expenses. For the 2024-2025 academic year, the standard UKRI doctoral stipend is approximately £19,237 per annum, though some projects may offer enhanced rates depending on the funding source.

Funding for Queen’s Belfast PhD projects comes from a diverse range of sources, reflecting the school’s success in attracting external research investment. UK Research and Innovation (UKRI) Research Councils, including the Medical Research Council (MRC) and Biotechnology and Biological Sciences Research Council (BBSRC), fund a significant proportion of studentships. The Wellcome Trust, Cancer Research UK, British Heart Foundation, and other major research charities also support PhD projects within MDBS. Additionally, the university offers its own funded studentships through the Vice-Chancellor’s Research Scholarships and other internal funding streams.

International students should pay particular attention to the funding eligibility criteria for each project, as some funding packages are restricted to UK or Republic of Ireland domiciled applicants. However, Queen’s University Belfast is increasingly offering funding that is open to international applicants, reflecting the university’s commitment to attracting the best doctoral talent regardless of nationality. The Queen’s University postgraduate funding page provides detailed information about available scholarships and bursaries, and prospective applicants are strongly encouraged to contact project supervisors directly to discuss funding options specific to their project of interest.

Beyond the core stipend, PhD students in MDBS typically receive additional financial support for conference attendance, research consumables, and training courses. The Thomas J. Moran Graduate School provides funded opportunities for professional development activities, and many supervisors maintain discretionary funds that support their students’ participation in national and international conferences. This comprehensive approach to PhD funding ensures that financial constraints do not limit the scope or ambition of doctoral research.

Admission Requirements for Queen’s Belfast PhD MDBS

Gaining admission to a Queen’s University Belfast PhD programme in MDBS requires demonstrating both academic excellence and research potential. The standard entry requirement is a first-class or upper second-class honours degree (2:1 or above) in a relevant discipline such as biomedical science, pharmacy, medicine, dentistry, biochemistry, molecular biology, or a closely related field. Some projects, particularly those involving advanced computational methods or specific laboratory techniques, may require a master’s degree or equivalent research experience as an additional entry criterion.

International applicants must meet the university’s English language requirements, which typically require an IELTS score of 6.5 overall with no individual component below 6.0. Equivalent scores from other recognised English language tests are accepted. Queen’s University Belfast also offers pre-sessional English language courses for applicants who narrowly miss the required language score, providing an alternative pathway into the PhD programme. The university has a dedicated International Office that supports prospective students with visa applications, pre-arrival information, and orientation programmes.

The application process for MDBS PhD projects is project-specific. Applicants are encouraged to review the available projects in the booklet, identify projects that match their research interests and academic background, and then contact the named supervisors directly to discuss the project in more detail before submitting a formal application. This initial conversation is a crucial step that allows both the applicant and supervisor to assess the fit, and it is common for supervisors to provide guidance on strengthening the application. Formal applications are submitted through the Queen’s University Belfast online application portal and typically require a CV, academic transcripts, a personal statement outlining research interests and motivations, and at least two academic references.

Competition for funded places is intense, with many projects receiving applications from across the UK and internationally. Applicants who can demonstrate relevant laboratory experience, published research, conference presentations, or industry placements will have a significant advantage. For a broader understanding of doctoral application processes across the UK, our guide to PhD applications at UK universities provides additional context and practical advice for international candidates.

The Thomas J. Moran Graduate School Experience

The Thomas J. Moran Graduate School is the centrepiece of Queen’s University Belfast’s commitment to doctoral researcher development, and it plays a particularly important role in the MDBS PhD experience. Described as a “state-of-the-art hub” for tailored training and development, the Graduate School goes far beyond the traditional model of PhD supervision by providing a comprehensive ecosystem of support that addresses the academic, professional, and personal needs of doctoral researchers.

At the heart of the Graduate School’s offering is its structured development programme, which is organised around four key pillars: thinkers, communicators, innovators, and leaders. The “thinkers” strand focuses on research methodology, critical analysis, and discipline-specific technical skills. The “communicators” pillar develops skills in academic writing, public engagement, and science communication — competencies that are increasingly essential for careers both within and beyond academia. The “innovators” programme introduces PhD students to concepts of enterprise, intellectual property, and the commercialisation of research, while the “leaders” strand cultivates project management, team leadership, and strategic planning capabilities.

The Graduate School also operates a dedicated mentoring programme that connects PhD students with experienced professionals from academia, industry, and the public sector. These mentoring relationships provide invaluable guidance on career planning, professional networking, and navigating the challenges of doctoral study. The Postgraduate Research Solutions Centre (PGRSC) offers additional one-to-one support for students facing academic difficulties, personal challenges, or wellbeing concerns, ensuring that no PhD student feels isolated or unsupported during their doctoral journey.

Cross-disciplinary networking is another hallmark of the Thomas J. Moran Graduate School experience. Regular events bring together PhD students from across all faculties at Queen’s, creating opportunities for collaboration and knowledge exchange that can spark innovative research ideas. For MDBS students, these events are particularly valuable because they provide exposure to perspectives from engineering, computer science, social sciences, and humanities that can enrich biomedical research in unexpected ways. The Graduate School’s “What’s Next” programme specifically addresses the transition from PhD to career, with workshops, employer events, and networking sessions that help students plan their post-doctoral pathways.

PhD Career Outcomes and Graduate Prospects at Queen’s Belfast

The career outcomes for PhD graduates from Queen’s University Belfast MDBS are consistently excellent, reflecting both the quality of doctoral training and the university’s strong employer networks. Queen’s is ranked in the top 10 in the UK for graduate prospects according to the Complete University Guide 2025, and this reputation extends to its doctoral graduates who consistently secure competitive positions in academia, industry, and the public sector within months of completing their PhD.

In academia, MDBS PhD graduates have secured post-doctoral research positions at leading institutions worldwide, including Oxford, Cambridge, Imperial College London, MIT, Stanford, and the Karolinska Institute. The rigorous 4-year training programme, combined with access to cutting-edge facilities and large-scale research datasets, produces graduates with a publication track record and technical skill set that makes them highly competitive for academic positions. Several former MDBS PhD students have gone on to establish their own independent research groups and secure major research grants.

Beyond academia, the pharmaceutical industry represents a major destination for MDBS PhD graduates, particularly those from the drug delivery, nanomedicine, and cancer research clusters. Belfast’s growing biotech and life sciences sector, anchored by companies like Almac Group, Norbrook Laboratories, and Randox Laboratories, provides immediate career opportunities, while the skills developed during the PhD — including project management, data analysis, and scientific communication — are equally valued by multinational pharmaceutical companies across the UK and Europe.

Government and non-governmental organisations also actively recruit Queen’s Belfast PhD graduates for roles in public health policy, health technology assessment, and research funding management. The combination of deep scientific expertise and the broader professional skills cultivated by the Thomas J. Moran Graduate School makes MDBS graduates particularly attractive to employers seeking individuals who can bridge the gap between scientific research and policy implementation. Whether pursuing an academic career or transitioning to industry, the Queen’s University Belfast PhD provides a foundation for sustained professional success and meaningful contribution to improving human health.

Living and Studying in Belfast as a PhD Researcher

Belfast offers PhD researchers an exceptional quality of life that combines cultural richness, affordability, and a vibrant social scene. As the capital of Northern Ireland, Belfast has undergone a remarkable transformation in recent decades, emerging as one of the most exciting and innovative cities in the UK and Ireland. For international PhD students, the city offers a welcoming and diverse community — Queen’s University Belfast hosts over 4,400 international students from more than 90 countries, creating a truly global campus environment.

One of Belfast’s most significant advantages for PhD students is its affordability. The cost of living in Belfast is substantially lower than in London, Edinburgh, or Dublin, meaning that PhD stipends stretch considerably further. Accommodation, whether university-managed or private, is significantly more affordable than in other major UK university cities, and the city’s compact size means that most amenities are accessible on foot or by bicycle from the university campus. The Queen’s Quarter neighbourhood, where much of the university is located, is a vibrant area with independent cafés, restaurants, bookshops, and cultural venues that cater to the student community.

Belfast’s cultural offering punches well above its weight. The city is home to world-class museums, galleries, and performance venues, including the Ulster Museum, the MAC (Metropolitan Arts Centre), and the Lyric Theatre. The Titanic Quarter, built on the site of the famous shipyard, has become one of Europe’s most celebrated urban regeneration projects and houses the award-winning Titanic Belfast museum. The city’s thriving food scene, live music venues, and annual festivals including the Belfast International Arts Festival and Cathedral Quarter Arts Festival ensure that PhD students have abundant opportunities for relaxation and cultural enrichment outside the laboratory.

The natural environment surrounding Belfast is equally appealing. The city sits at the head of Belfast Lough, with easy access to the stunning Antrim Coast, the Mourne Mountains, and the Giant’s Causeway — all within an hour’s drive. For PhD students who value outdoor activities, hiking, surfing, and exploring Northern Ireland’s dramatic landscapes provide a perfect counterbalance to the intellectual demands of doctoral research. Queen’s University Belfast is ranked 4th in the world for international outlook, and the university’s commitment to supporting international researchers extends to practical assistance with housing, healthcare registration, and social integration programmes that help new arrivals settle quickly into Belfast life.